See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
MFA Financial, Inc. (MFA) - free report >>
Groupon, Inc. (GRPN) - free report >>
Apellis Pharmaceuticals, Inc. (APLS) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MFA Financial, Inc. (MFA) - free report >>
Groupon, Inc. (GRPN) - free report >>
Apellis Pharmaceuticals, Inc. (APLS) - free report >>
Image: Bigstock
New Strong Buy Stocks for October 24th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
MFA Financial, Inc. (MFA - Free Report) : This real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
MFA Financial, Inc. Price and Consensus
MFA Financial, Inc. price-consensus-chart | MFA Financial, Inc. Quote
Griffon Corporation (GFF - Free Report) : This diversified management and holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Griffon Corporation Price and Consensus
Griffon Corporation price-consensus-chart | Griffon Corporation Quote
Office Properties Income Trust (OPI - Free Report) : This national real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.
Office Properties Income Trust Price and Consensus
Office Properties Income Trust price-consensus-chart | Office Properties Income Trust Quote
Apellis Pharmaceuticals, Inc. (APLS - Free Report) : This commercial-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.
Apellis Pharmaceuticals, Inc. Price and Consensus
Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote
Groupon, Inc. (GRPN - Free Report) : This marketplace which connects consumers to merchants has seen the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
Groupon, Inc. Price and Consensus
Groupon, Inc. price-consensus-chart | Groupon, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.